Turnstone Biologics Corp.

TSBX

TSBXTurnstone Biologics Corp. US flag

NASDAQ Global Market

0.36

USD

- -

8.21MMarket Cap

Income Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y
Sales/Revenue/Turnover	101	73	19	- -
+ Sales & Services Revenue	101	73	19	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	-101	-73	-19	- -
- Operating Expenses	68	105	78	72
+ Selling, General & Admin	14	18	18	16
+ Research & Development	55	87	60	56
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	33	-32	-59	-72
- Non-Operating (Income) Loss	-1	-1	-4	-2
+ Interest Expense, Net	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	-1	-1	-4	-2
Pretax Income	34	-31	-55	-71
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	33	-31	-55	-71
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	33	-31	-55	-71
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	33	-31	-55	-71
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	33	-31	-55	-71
EBIT	33	-32	-59	-72
EBITDA	34	-28	-56	-71
EBITDA Margin (%)	33.94	-37.82	-291.28	- -
EBITA	33	-32	-59	-72
Gross Margin (%)	100	100	100	- -
Operating Margin (%)	32.57	-43.15	-305.77	- -
Profit Margin (%)	32.84	-42.07	-285.92	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	1	4	3	2
Basic Weighted Avg Shares	22	22	12	23
Basic EPS, GAAP	1.5	-1.39	-4.77	-3.07
Basic EPS from Cont Ops	1.5	-1.39	-4.77	-3.07
Diluted Weighted Avg Shares	22	22	12	23
Diluted EPS, GAAP	1.5	-1.39	-4.77	-3.07
Diluted EPS from Cont Ops	1.5	-1.39	-4.77	-3.07

Balance Sheet (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y
Total Current Assets	177	98	103	34
+ Cash, Cash Equivalents & STI	161	82	95	29
+ Cash & Cash Equivalents	123	35	18	29
+ ST Investments	38	47	77	- -
+ Accounts & Notes Receiv	7	9	- -	- -
+ Accounts Receivable, Net	7	9	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	10	7	8	5
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	10	17	10	6
+ Property, Plant & Equip, Net	9	14	9	5
+ Property, Plant & Equip	13	20	16	13
- Accumulated Depreciation	3	6	7	8
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	1	3	1	1
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	1	3	1	1
Total Assets	187	115	113	40
+ Payables & Accruals	18	15	6	6
+ Accounts Payable	- -	3	- -	1
+ Accrued Taxes	- -	- -	- -	1
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	18	11	6	4
+ ST Debt	1	2	2	1
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	1	2	2	1
+ Other ST Liabilities	36	18	4	1
+ Deferred Revenue	33	15	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	3	3	4	1
Total Current Liabilities	55	35	12	8
+ LT Debt	2	3	1	- -
+ LT Borrowings	- -	- -	- -	- -
+ LT Finance Leases	2	3	1	- -
+ Other LT Liabilities	212	178	1	- -
+ Accrued Liabilities	39	4	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	173	174	1	- -
Total Noncurrent Liabilities	214	182	2	- -
Total Liabilities	269	216	14	9
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	9	21	276	279
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	9	21	276	279
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-91	-122	-177	-248
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-82	-101	99	31
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-82	-101	99	31
Total Liabilities & Equity	187	115	113	40
Shares Outstanding	22	22	23	23
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	3	5	3	1
Net Debt	-123	-35	-18	-29
Net Debt to Equity	150.74	34.23	-18.04	-91.92
Tangible Common Equity Ratio	-43.71	-88.28	87.46	78.4
Current Ratio	3.23	2.81	8.57	4.17
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y
+ Net Income	33	-31	-55	-71
+ Depreciation & Amortization	1	4	3	2
+ Non-Cash Items	5	14	4	2
+ Stock-Based Compensation	3	6	4	4
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	2	- -
+ Other Non-Cash Adj	3	7	-2	-2
+ Chg in Non-Cash Work Cap	-86	-58	-18	- -
+ (Inc) Dec in Accts Receiv	-2	-2	9	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-3	- -	- -	1
+ Inc (Dec) in Accts Payable	2	-1	-5	-3
+ Inc (Dec) in Other	-83	-54	-22	1
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-46	-71	-66	-67
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	-3	-5	-1	- -
+ Acq of Fixed Prod Assets	-3	-5	-1	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	78	- -
+ Increase in Capital Stock	- -	- -	78	- -
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	-10	-27	79
+ Dec in LT Investment	41	50	82	86
+ Inc in LT Investment	-41	-60	-110	-7
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	-3	-15	-28	79
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	80	-3	-1	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	80	-3	77	- -
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	31	-89	-17	11
EBITDA	34	-28	-56	-71
EBITDA Margin (%)	33.94	-37.82	-291.28	- -
Free Cash Flow	-49	-76	-67	-68
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	-49	- -	- -	- -
Free Cash Flow to Equity	- -	-76	-67	-68
Free Cash Flow per Basic Share	-2.21	-3.44	-5.83	-2.94
Price/Free Cash Flow	- -	- -	-0.45	-0.17
Cash Flow to Net Income	-1.37	2.3	1.2	0.95
Capital Expenditures	-3	-5	-1	- -